SCHEDULE: Goldman Sachs Updates Nevro Corp. Stake
Beneficial Ownership Update
Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC reported a 0.0% beneficial ownership stake in Nevro Corp. common stock as of June 30, 2025.
Summary
- The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Nevro Corp.
- As of June 30, 2025, the aggregate amount beneficially owned by each reporting person is 1,172 shares of Nevro Corp. common stock.
- This represents 0.0% of the class of Nevro Corp.'s common stock.
- Goldman Sachs & Co. LLC, a registered broker-dealer and investment adviser, holds these securities as a subsidiary of The Goldman Sachs Group, Inc.
- The reporting persons have shared voting power over 905 shares and shared dispositive power over 1,172 shares.
Sentiment
Score: 5
Explanation: The filing is a standard Schedule 13G amendment reporting a passive, non-material ownership stake, indicating a neutral sentiment as it does not convey positive or negative operational or financial news for the issuer.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 07/16/2025 | Date Power of Attorney was subscribed |
| 07/17/2025 | Date of filing signature |
| 07/16/2026 | Expiration date of the Power of Attorney |
Keywords
Nevro Corp, Goldman Sachs, Schedule 13G, Beneficial Ownership, Common Stock, NVRO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.